The Global End-Tidal Carbon Dioxide Monitors Market was valued at USD 491.73 Million and is projected to reach a market size of USD 800.00 Million by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 7.2%.
Industry Overview
The system that detects the presence or concentration of CO2, which is regarded as a harmful gas in the natural environment and is present in a variety of natural environments, is known as a carbon dioxide (CO2) monitor. Accurate and quick carbon dioxide detection is essential for many industries to prevent gas concentrations of harmful toxins. The continuous monitoring of the gas is done using CO2 detectors.
One of the key factors propelling the growth of the carbon dioxide (CO2) monitors market is the rising incidence of airborne diseases like asthma and chronic bronchitis among people around the world. The market is growing as a result of strict regulations being implemented across a variety of industries to protect people from potentially harmful gases released by industrial activity and steadily rising pollution levels. The market is also influenced by the use of monitors to detect carbon dioxide accurately and quickly before it reaches toxic levels and by mergers, acquisitions, joint ventures, collaborations, and partnerships. Additionally, the market for carbon dioxide (CO2) monitors is benefited from urbanization, industrialization, research and development, government activities, and increased public awareness. Additionally, during the forecast period of 2022 to 2022, technical advances in monitors offer lucrative prospects to market participants.
Due to lockdowns brought on by COVID-19, capnography device production facilities had to temporarily shut down at the start of 2020. Despite this, the market for capnography devices has grown as a result of the high number of hospital admissions and growing public awareness of wellbeing. As a result, the capnography equipment market has grown positively during this epidemic.
Hospitalizations have gone up as a result of the COVID-19 outbreak, an unprecedented public health hazard. Worldwide, the coronavirus pandemic outbreak has affected millions of individuals. According to the researchers' meta-analysis of seven studies, patients with severe COPD may be more susceptible to COVID-19 problems since COVID-19 has an impact on the respiratory system. Due to the worldwide postponement of all elective surgeries in early 2020, the unprecedented COVID-19 effect had a moderate impact on practices for airway management therapies.
The rising number of respiratory diseases is set to propel the capnography devices market progression
One of the main elements promoting the industry's growth is the rising number of people suffering from respiratory disorders worldwide. According to an article in the National Center for Biotechnology Information (NCBI), the number of lung cancer fatalities worldwide is expected to increase by 86% by 2035, and in some countries, such as America, the Western Pacific, and South-East Asia, it is predicted that number will double. This emphasizes the growing demand for capnography equipment to detect early respiratory depression and airway abnormalities, particularly during sedation, preventing serious complications. Additionally, it is anticipated that factors including tobacco use, family history of lung cancer, and air pollution, among others, would contribute to the rise in the number of people with this disease.
It is anticipated that several benefits provided by hand-held capnography devices would influence people's selection for these instruments
The market for capnography devices' hand-held segment was valued at USD 267 million in 2020, driven mostly by the multiple benefits these instruments provide. These portable tools are made specifically for each patient's condition and doctor's preferences to allow precise movement of the instrument. To test the carbon dioxide content of inspired and expired air, these instruments are simple to use and incredibly portable. Mobile spot-checking and stationary & transport uses can both be accommodated by the battery-operated design of hand-held capnography equipment. With its compact design, it offers a wide range of movement and uncomplicated positioning. Modern hand-held capnography systems support both intubated and non-intubated patients and have a visual and audible alarm as well as sidestream technology.
The high cost associated with the devices will challenge the market growth
On the other hand, high system and maintenance costs are anticipated to restrain market expansion. During the forecast period of 2022–2030, the detrimental effects of COVID-19 on numerous industries are anticipated to be a challenge to the carbon dioxide (CO2) monitors market.
GLOBAL END-TIDAL CARBON DIOXIDE MONITORS MARKET REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2023 - 2030 |
Base Year |
2023 |
Forecast Period |
2024- 2030 |
CAGR |
7.2 % |
Segments Covered |
By Technology, Component, End Use, Application and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
Key Companies Profiled |
Criticare Technologies, Inc. (USA), Drager Medical GmbH (Germany), GE Healthcare (USA), Invivo Corporation (USA), Masimo Corporation (USA), Medtronic plc (Irelanthe the d), Mindray DS USA, Inc. (USA), Nihon Kohden Corporation (Japan), Nonin Medical, Inc. (USA), OSI Systems, Inc. (USA), Philips Healthcare (Netherlands), Radiometer Medical ApS (Denmark), Smiths Medical (USA), Thames Medical (UK), Thames Medical (Uk) |
This research report on the global end-tribal dioxide monitors market has been segmented and sub-segmented based on, type, application, and Geography & region.
Side Stream
Main Stream
Micro Stream
Side Stream stands as the largest segment in the market. This technology involves the extraction of a small sample of exhaled air from the patient's airway and transporting it to a remote sensor for analysis. Side Stream monitoring is widely used in various clinical settings, providing continuous and accurate EtCO2 measurements.
The fastest-growing technology during the forecast period is Micro Stream. This innovative technology integrates a tiny capnography sensor directly into the patient's airway, allowing for real-time and continuous EtCO2 monitoring. The compact design and minimal invasiveness of Micro Stream monitoring have garnered significant attention from healthcare professionals, leading to its rapid adoption in critical care and procedural sedation.
Global End-Tidal Carbon Dioxide Market- By Component
Original Equipment Manufacturer (OEM)
Others
Original Equipment Manufacturers (OEM) dominate the market, serving as the largest segment. OEMs are responsible for designing, manufacturing, and distributing EtCO2 monitors and related equipment. Their expertise and established reputation in the market have contributed to their significant share in the EtCO2 industry.
During the forecast period, the fastest-growing segment is Others, which includes third-party manufacturers and aftermarket suppliers. With the increasing demand for EtCO2 monitoring devices, several new players have entered the market, offering competitive and cost-effective solutions. The growth of Others is fueled by their ability to cater to diverse customer needs and provide specialized products and services.
Global End-Tidal Carbon Dioxide Market- By Application
Emergency Medicine
Critical Care
Procedural Sedation
Pain Management
Others
Critical Care stands as the largest segment in this category, reflecting the significance of EtCO2 monitoring in intensive care units and high-acuity settings. In critical care, continuous EtCO2 monitoring is vital for assessing ventilation, detecting respiratory distress, and guiding appropriate interventions.
The fastest-growing application during the forecast period is Medicine. EtCO2 monitoring is becoming increasingly integrated into routine medical care across different specialties. In medicine, EtCO2 monitoring aids in patient assessment during surgeries, procedures, and sedation, ensuring patient safety and optimizing treatment outcomes.
Hospitals
Ambulatory Surgical Centers
Others
Hospitals stand as the largest segment in the EtCO2 market by end use. These healthcare institutions play a crucial role in patient care, and EtCO2 monitoring is an essential tool in their arsenal. Hospitals utilize EtCO2 monitoring in a wide range of medical procedures, surgeries, and critical care settings. The technology aids medical professionals in assessing patient ventilation and ensuring timely intervention in case of respiratory distress. The emphasis on patient safety and the need for efficient respiratory monitoring have led to the widespread adoption of EtCO2 monitoring in hospitals.
The fastest-growing segment in the EtCO2 market by end use is surgical centers. These specialized facilities focus on performing surgeries and other invasive procedures. EtCO2 monitoring has emerged as a critical component in surgical centers, where precise respiratory monitoring is essential during anesthesia administration and patient recovery. The technology enables surgeons and anesthesiologists to closely monitor a patient's respiratory status and make informed decisions, contributing to improved surgical outcomes and patient recovery
North America
Europe
Asia-Pacific
Latin America
The Middle East and Africa
North America emerges as the largest region in the EtCO2 market. The region's well-established healthcare infrastructure and commitment to advancing medical technologies have contributed to the widespread adoption of EtCO2 monitoring. In North America, healthcare providers prioritize patient safety and seek innovative solutions to improve respiratory care. EtCO2 monitoring plays a vital role in critical care units, surgical settings, and emergency medicine, providing valuable data to guide medical interventions and ensure optimal patient outcomes.
The Asia-Pacific region is the fastest-growing segment in the EtCO2 market during the forecast period. With a rapidly expanding population and increasing healthcare investments, Asia-Pacific countries are focusing on enhancing patient care and safety. EtCO2 monitoring is gaining traction in the region, particularly in countries like China, Japan, and India, where the demand for advanced medical technologies is on the rise. The COVID-19 pandemic has further underscored the importance of respiratory monitoring, driving the adoption of EtCO2 monitoring systems in Asia-Pacific healthcare facilities.
Criticare Technologies, Inc. (USA)
Drager Medical GmbH (Germany)
GE Healthcare (USA)
Invivo Corporation (USA)
Masimo Corporation (USA)
Medtronic plc (Irelanthe the d)
Mindray DS USA, Inc. (USA)
Nihon Kohden Corporation (Japan)
Nonin Medical, Inc. (USA)
OSI Systems, Inc. (USA)
Philips Healthcare (Netherlands)
Radiometer Medical ApS (Denmark)
Smiths Medical (USA)
Thames Medical (UK)
Thames Medical (Uk)
Regulatory Approval: - In 2021, Radius PCG received U.S. FDA approval, according to Masimo Corporation. It is a portable real-time capnograph with Bluetooth wireless connectivity that offers patients of all ages seamless, tetherless mainstream capnography. This approval gave the business a competitive advantage and strengthened its standing in the market.
Business Partnership: - In 2020, To introduce advancements in patient monitoring solutions, including capnography devices, Philips Healthcare and Masimo Corporation announced their alliance. This provided new options to build capnography equipment that are incredibly effective.
Chapter 1. END-TIDAL CARBON DIOXIDE MONITORS MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. END-TIDAL CARBON DIOXIDE MONITORS MARKET – Executive Summary
2.1. Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2024 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3. END-TIDAL CARBON DIOXIDE MONITORS MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. END-TIDAL CARBON DIOXIDE MONITORS MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. END-TIDAL CARBON DIOXIDE MONITORS MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. END-TIDAL CARBON DIOXIDE MONITORS MARKET – By Technology
6.1. Side Stream
6.2. Main Stream
6.3. Micro Stream
Chapter 7. END-TIDAL CARBON DIOXIDE MONITORS MARKET – By Component
7.1. Original Equipment Manufacturere (OEM)
7.2. Others
Chapter 8. END-TIDAL CARBON DIOXIDE MONITORS MARKET – By Application
8.1. Emergency Medicine
8.2. Critical Care
8.3. Procedural Sedation
8.4. Pain Managements
8.5. Others
Chapter 9. END-TIDAL CARBON DIOXIDE MONITORS MARKET – By End Use
9.1. Hospitals
9.2. Ambulatory Surgical Centres
9.3. Others
Chapter 10. END-TIDAL CARBON DIOXIDE MONITORS MARKET – By Region
10.1. North America
10.2. Europe
10.3. Asia - Pacific
10.4. Latin America
10.5. The Middle East
10.6. Africa
Chapter 11. END-TIDAL CARBON DIOXIDE MONITORS MARKET – By Companies
11.1. Criticare Technologies Inc. (USA)
11.2. Drager Medical Gmbh (Germany)
11.3. GE Healthcare
11.4. Invivo Corporation (USA)
11.5. Masimo Corporation (USA)
11.6. Medtronic plc (Irelanthe the d)
11.7. Mindray DS USA Inc. (USA)
11.8. Nihon Kohden Corporation (Japan)
11.9. Nonin Medical Inc (USA)
11.10. OSI Systems , Inc. (USA)
11.11. Philips Healthcare (Netherlands)
11.12. Radiometer Medical Aps (Denmark)
11.13. Smiths Medical (USA)
11.14. Thames Medical (UK)
11.15. Thames Medical (UK)
2500
4250
5250
6900
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.